Myomo, Inc. (MYO): who owns it and who trades it
As of Nov 16, 2026, MYO insiders reported 8 open-market sales worth $231K and 13 purchases worth $443K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Harry Kovelman (Chief Medical Officer), with $132K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Myomo
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MYO
80 funds and institutions reported MYO shares worth $12.7M at the end of Q2 2026, about 32% of the company. The largest holder is Rosalind Advisors, Inc. with 9.4%.
Funds and institutions (13F) 32%Everyone else 68%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.64M | 9.45% | $3.8M | – |
| Vanguard Capital Management LLC | 1.64M | 4.25% | $1.7M | – |
| AQR Capital Management LLC | 928,268 | 2.41% | $965K | – |
| Jefferies Financial Group Inc. | 704,275 | 1.83% | $732K | – |
| Jane Street Group, LLC | 596,352 | 1.55% | $620K | – |
| Clearstead Advisors, LLC | 425,609 | 1.11% | $443K | – |
| UBS Group AG | 413,679 | 1.07% | $430K | – |
| Geode Capital Management, LLC | 344,417 | 0.89% | $358K | – |
| LPL Financial LLC | 308,000 | 0.80% | $320K | – |
| Palumbo Wealth Management LLC | 299,776 | 0.78% | $312K | – |
| Gsa Capital Partners LLP | 271,876 | 0.71% | $283K | – |
| Millennium Management LLC | 271,294 | 0.70% | $282K | – |
| BlackRock, Inc. | 223,217 | 0.58% | $232K | – |
| Vanguard Fiduciary Trust Co | 207,677 | 0.54% | $216K | – |
| BNP Paribas Financial Markets | 139,194 | 0.36% | $145K | – |
| Ieq Capital, LLC | 127,749 | 0.33% | $133K | – |
| Susquehanna International Group, LLP | 120,791 | 0.31% | $126K | – |
| XTX Topco Ltd | 110,028 | 0.29% | $114K | – |
| State Street Corp | 105,875 | 0.27% | $110K | – |
| Citadel Advisors LLC | 102,518 | 0.27% | $107K | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, MYO insiders reported $443K of open-market purchases and $231K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Harry Kovelman | Chief Medical Officer | Sale | 15,844 | $1.27 | $20.1K | Form 4 |
| Sep 11, 2026 | Harry Kovelman | Chief Medical Officer | Sale | 15,488 | $1.27 | $19.7K | Form 4 |
| Sep 2, 2026 | Milton Mayo Morris | Director | Sale | 15,000 | $1.41 | $21.1K | Form 4 |
| Aug 20, 2026 | Harry Kovelman | Chief Medical Officer | Sale | 17,500 | $1.73 | $30.3K | Form 4 |
| Aug 20, 2026 | Harry Kovelman | Chief Medical Officer | Sale | 17,250 | $1.73 | $29.8K | Form 4 |
| Jun 5, 2026 | Thomas F Kirk | Director | Purchase | 40,002 | $1.27 | $50.8K | Form 4 |
| May 28, 2026 | Thomas F Kirk | Director | Purchase | 25,000 | $0.99 | $24.8K | Form 4 |
| May 28, 2026 | Harry Kovelman | Chief Medical Officer | Sale | 11,536 | $1.02 | $11.8K | Form 4 |
| May 27, 2026 | Harry Kovelman | Chief Medical Officer | Sale | 20,464 | $1.00 | $20.5K | Form 4 |
| May 18, 2026 | Thomas F Kirk | Director | Purchase | 43,401 | $0.91 | $39.5K | Form 4 |
| May 15, 2026 | Thomas F Kirk | Director | Purchase | 31,605 | $0.91 | $28.8K | Form 4 |
| May 15, 2026 | Joseph M. Manko Jr. | Director | Purchase | 30,367 | $0.89 | $27K | Form 4 |
| May 14, 2026 | Micah Mitchell | Chief Commercial Officer | Sale | 90,231 | $0.86 | $77.6K | Form 4 |
| May 14, 2026 | Joseph M. Manko Jr. | Director | Purchase | 170,830 | $0.86 | $147K | Form 4 |
| Mar 16, 2026 | Heather C Getz | Director | Purchase | 20,000 | $0.70 | $14K | Form 4 |
| Mar 13, 2026 | Thomas F Kirk | Director | Purchase | 72,000 | $0.71 | $51.1K | Form 4 |
| Mar 12, 2026 | Heather C Getz | Director | Purchase | 70,000 | $0.73 | $51.1K | Form 4 |
| Nov 21, 2025 | Thomas F Kirk | Director | Purchase | 2,535 | $0.72 | $1.8K | Form 4 |
| Nov 20, 2025 | Thomas F Kirk | Director | Purchase | 4,902 | $0.72 | $3.5K | Form 4 |
| Nov 19, 2025 | Thomas Aloysius Crowley Jr. | Director | Purchase | 385 | $0.77 | $296 | Form 4 |
| Nov 18, 2025 | Thomas Aloysius Crowley Jr. | Director | Purchase | 4,000 | $0.73 | $2.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Thomas F Kirk | Director | $200K | – | Jun 5, 2026 |
| Joseph M. Manko Jr. | Director | $174K | – | May 15, 2026 |
| Harry Kovelman | Chief Medical Officer | – | $132K | Sep 11, 2026 |
| Micah Mitchell | Chief Commercial Officer | – | $77.6K | May 14, 2026 |
| Heather C Getz | Director | $65.1K | – | Mar 16, 2026 |
| Milton Mayo Morris | Director | – | $21.1K | Sep 2, 2026 |
| Thomas Aloysius Crowley Jr. | Director | $3.2K | – | Nov 19, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MYO short interest
Low short interest. 2.9% of MYO shares are sold short: about 1 share in 34. Over the last 12 reports the number of shares short went down 70%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.16M MYO shares were sold short, 2.9% of the shares outstanding, up 8.6% from the report before. At the average daily volume of 201,201 shares, buying them all back would take about 5.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.16M | 2.92% | +9% | 201,201 | 5.8 |
| Oct 15, 2026 | 1.06M | 2.69% | -0% | 276,126 | 3.9 |
| Sep 30, 2026 | 1.07M | 2.69% | -11% | 406,828 | 2.6 |
| Sep 15, 2026 | 1.20M | 3.02% | +0% | 335,257 | 3.6 |
| Aug 31, 2026 | 1.19M | 3.01% | +6% | 742,856 | 1.6 |
| Aug 14, 2026 | 1.12M | 2.84% | -39% | 889,567 | 1.3 |
| Jul 31, 2026 | 1.85M | 4.66% | -23% | 329,076 | 5.6 |
| Jul 15, 2026 | 2.41M | 6.26% | -1% | 349,228 | 6.9 |
| Jun 30, 2026 | 2.44M | 6.33% | -26% | 1.47M | 1.7 |
| Jun 15, 2026 | 3.32M | 8.61% | -4% | 1.53M | 2.2 |
| May 29, 2026 | 3.44M | 8.94% | -10% | 643,423 | 5.3 |
| May 15, 2026 | 3.81M | 9.90% | -1% | 416,497 | 9.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Myomo company events
Myomo filed 9 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 9, 2026.
- Nov 9, 2026ResultsReleased financial results. Filing
- Aug 5, 2026ResultsReleased financial results. Filing
- Jun 29, 2026LeadershipAmended an earlier report. Amendment No. 3 to the Company's 2018 Stock Option and Incentive Plan, which was inadvertently labeled as Exhibit 3.1, (ii) to file under Item 5.03 an amendment to the Company's Eighth Amended and Restated Certificate of Incorporation, as amended, which was inadvertently labeled as Exhibit 10.1… Filing
- Jun 26, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. Filing
- May 13, 2026LeadershipUpon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Myomo, Inc., the Board appointed Joseph M. Manko Jr. to join the Board, effective on May 9, 2026. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 16, 2026LeadershipUpon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Myomo, Inc., the Board appointed William J. Febbo to join the Board, effective on April 14, 2026. Filing
- Mar 9, 2026ResultsReleased financial results. Filing
- Dec 16, 2025LeadershipThe Compensation Committee of the Board of Directors of Myomo, Inc. approved a salary-for-restricted stock units program open to all salaried employees pursuant to which (i) Paul Gudonis, the Company’s Chief Executive Officer, voluntarily elected to reduce his base salary for 2026 by 10% in… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Myomo financials
Famous investors that hold MYO
3 of the 50 well-known investors we track reported holding MYO in their latest 13F filing. The largest position is Israel Englander's, worth $386K.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 247,380 | $386K | 0.0% | -9% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 109,786 | $171K | 0.0% | +7% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 101,700 | $159K | 0.0% | +110% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named MYO in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 12, 2026 | Rosalind Advisors, Inc. | 13G/A | 9.9% |
| Nov 12, 2026 | Rosalind Advisors, Inc. | 13G/A | 9.9% |
Questions about Myomo, Inc. (MYO) stock
Who owns the most MYO stock?
The largest reported owner of Myomo, Inc. (MYO) is Rosalind Advisors, Inc., with 9.4% of the company. In total, 80 funds and institutions reported holding MYO at the end of Q2 2026, together about 32% of the shares. See the largest owners.
Are MYO insiders buying or selling?
In the last 12 months, MYO insiders reported 13 open-market purchases worth $443K and 8 sales worth $231K. The latest trade was on Sep 11, 2026. See every trade.
What is the short interest in MYO?
As of Oct 30, 2026, 1.16M MYO shares were sold short, 2.9% of the shares outstanding, up 8.6% from the report before. At the average daily volume of 201,201 shares, buying them all back would take about 5.8 trading days (days to cover). See the history.
Which famous investors hold MYO?
3 of the 50 well-known investors we track reported MYO in their latest 13F filing, including Israel Englander, Ken Griffin, Jim Simons. The largest position is worth $386K. See all holders.
Executive pay
Myomo's chief executive was paid a total of $1.2M for the year ended Dec 31, 2025, down 3% from $1.2M the year before. In the last 12 months, Myomo's executives and directors bought $443K of stock on the open market and sold $309K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.